Trial intelligence / Profile preview

Metformin in CABG trial

NL-OMON38069Recruiting

Sponsor
Radboud University Medical Center
Start
Nov 2011
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in myocardial ischemia-reperfusion injury comparing Metformin pretreatment with Placebo pretreatment (2 arms). Primary endpoint: High-sensitive troponin I levels. Started Nov 2011; status: recruiting.

02

Drugs

metformin
03

Conditions

myocardial ischemia-reperfusion injury

Beyond the preview

Go deeper on NL-OMON38069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call